JPM vs TMO: Which Is the Better Buy?
Side-by-side comparison of JPMorgan Chase & Co. and Thermo Fisher Scientific Inc. — fair value, conviction, valuation metrics, and QuantHub research signals.
Updated 2026-05-04.
JPMorgan Chase & Co. · Financial Services
$316.99
+139.7% upside to fair value
Grade C
High Quality
VS
Thermo Fisher Scientific Inc. · Healthcare
$462.60
+10.1% upside to fair value
Grade B
QuantHub Verdict
JPM has more upside to fair value
(+139.7%).
JPM trades at a lower forward P/E
(15.0x).
These are model outputs — not personalized investment advice.
See all research →
Valuation & Fundamentals
| Metric |
JPM |
TMO |
| Current Price |
$316.99 |
$462.60 |
| Fair Value Estimate |
$759.82 |
$509.20 |
| Upside to Fair Value |
+139.7%
|
+10.1%
|
| Market Cap |
$854.9B |
$171.9B |
| Forward P/E |
15.0x
|
25.1x
|
| EV / EBITDA |
21.8x
|
19.0x
|
| Price / Sales |
3.0x
|
3.8x
|
| Price / FCF |
8.5x
|
25.5x
|
| Revenue Growth YoY |
+6.9%
|
+6.2%
|
| Gross Margin |
60.9%
|
39.4%
|
| Operating Margin |
26.2%
|
17.8%
|
| Return on Equity |
16.3%
|
13.3%
|
| Dividend Yield |
0% |
0% |
| FCF Yield |
11.79%
|
3.92%
|
| Analyst Consensus |
Buy
|
Strong Buy
|
Investment Thesis
JPMorgan Chase & Co. is a leading diversified financial services firm with a strong competitive moat driven by its scale, diversified revenue streams, and long-tenured leadership. The company operates across four main segments: Commercial & Investment Bank, Consumer & Community Banking, Asset & Wealth Management, and Corporate, generating $279.75 billion in revenue in fiscal 2025. Its durable com…
Thermo Fisher Scientific Inc. operates in the healthcare sector, specializing in medical diagnostics and research tools across four main segments: Laboratory Products and Biopharma Services, Life Sciences Solutions, Analytical Instruments, and Specialty Diagnostics. The company demonstrates medium business quality with steady revenue growth of 6.2% and earnings growth of 9.6% in the most recent q…
Accumulation Zones
| Metric |
JPM |
TMO |
| Zone Low |
$569.87 |
$381.90 |
| Zone High |
$645.85 |
$432.82 |
| In Buy Zone? |
Yes
|
No
|